Feb 20, 2007 · The FDA has approved a vascular shunt (Temporary Limb Salvage Shunt), an in vitro diagnostic multivariate index assay (MammaPrint), and an absorbable suture (TephaFLEX).

Dec 22, 2025 · For women with BRCA mutations, hormone therapy after prophylactic oophorectomy may not raise breast cancer risk, while estrogen-only therapy is associated with …

Tocilizumab, a biologic disease-modifying antirheumatic drug targeting interleukin 6, reduces disease activity more effectively than prednisone in patients with active rheumatoid arthritis.

Dec 24, 2025 · Researchers report links between third-trimester exposure to endocrine disruptors and higher behavioural risk scores in early childhood.

Paternal exposure to methotrexate before conception is not linked to increased risks for adverse birth outcomes, but exposures to some other immunosuppressants and biologics do carry risks.

The MHRA has approved Siiltibcy, a new skin test that uses recombinant proteins to more accurately detect tuberculosis in adults and children.

Medication use for opioid use disorder has increased but remains low, and methadone and buprenorphine are linked to reduced risk for opioid overdose, a new study shows.

Data from a new mouse model may help advance therapeutic development in celiac disease, including improved TG2 inhibitors and strategies to deplete autoreactive B cells.

Aug 18, 2025 · US regulators sent seemingly mixed messages this month about the outlook for animal-derived, or desiccated, thyroid medicines.

Oct 31, 2025 · Hormonal contraceptive-associated breast cancer risk differs by progestin type, with desogestrel-containing products linked to a higher risk than levonorgestrel-containing …